Aptivus Labeling Should Note Added Efficacy With Fuzeon, Committee Says

Labeling for Boehringer Ingelheim's HIV therapy Aptivus should note that tipranavir is most efficacious when used in combination with certain HIV therapies, particularlyFuzeon, members of FDA's Antiviral Drugs Advisory Committee said May 19